54 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS

✍ Scribed by A. Pietrangelo; P. Brissot; H. Bonkovsky; C. Niederau; L. Rojkjaer; R. Weitzman; P. Williamson; O. Schoenborn-Kellenberger; P. Phatak

• Book ID: 117377065
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 52 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(09)60056-8